UBR5 and breast carcinoma: To validate these results, we demonstrated that knockdown of RNF111 or UBR5 rescued ER degradation by basic amino or acrylic acid SERDs, respectively, in reporter assays and of endogenously expressed ER in breast cancer cells (Figures 6D and S8C–S8F).